{"SPADE_UN_28501": {"Sequence Information": {"Peptide Name": "", "Sequence": "GXRKXHKXWA", "Sequence Length": 10, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides.", "Pubmed ID": "20176897", "Reference": "Antimicrob Agents Chemother. 2010;54:1693-1699", "Author": "Anantharaman A, Rizvi MS, Sahal D", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/20176897"}, {"Title": "Antimicrobial action of prototypic amphipathic cationic decapeptides and their branched dimers.", "Pubmed ID": "19432402", "Reference": "Biochemistry. 2009;48:5642-5657", "Author": "Dewan PC, Anantharaman A, Chauhan VS, Sahal D", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/19432402"}], "SPADE ID": "SPADE_UN_28501", "Similar Sequences": [{"SPADE_ID": "SPADE_N_02394", "Similarity": 1.0, "Sequence": "AHCLAIGRK"}, {"SPADE_ID": "SPADE_N_11263", "Similarity": 1.0, "Sequence": "GRKHKWAAGRKHKWA"}, {"SPADE_ID": "SPADE_N_11828", "Similarity": 1.0, "Sequence": "AAHCLAIGRK"}], "Hemolytic Activity": "Human erythrocytes:-=NA", "Target Organism": "Escherichia coli ML-35p(MIC=135.8µg/ml),Escherichia coli ML-35p(MBC=500µM),Staphylococcus aureus ATCC 700699(MIC=450µM),Staphylococcus aureus ATCC 700699(MBC=>500µM),Mouse fibrosarcoma L929(no activity data),Human cervical carcinoma HeLa(no activity data)"}}}